It has been a rough session for IperionX Ltd (ASX: IPX) shares on Thursday.
The S&P/ASX 300 Index (ASX: XKO) critical minerals stock is sliding even after releasing a major update on its US project.
At the time of writing, the IperionX share price is down 10.30% to $5.31.
Today’s weakness follows a strong run for the stock. IperionX shares are still up around 18% in a month and 43% over the past year.
Here’s what was in the update.
A big US project update
According to the release, IperionX has completed the definitive feasibility study for its Titan Critical Minerals Project in Tennessee.
The project is designed to produce titanium minerals, zircon concentrate, and heavy rare earth concentrate from the McNairy Formation.
IperionX said the DFS showed an after-tax net present value of US$813 million, an after-tax internal rate of return of 39%, and a payback period of 3.6 years.
It also forecast life-of-mine EBITDA of US$2.8 billion and after-tax free cash flow of US$1.9 billion.
The project has a 14-year mine plan and is expected to be developed in stages. Phase 1 development capital is estimated at US$228 million, while Phase 2 requires a further US$153.2 million.
That brings total development capital to US$381.3 million.
The maiden ore reserve was another major part of the update. Titan has a reserve of 117 million tonnes at 3.2% total heavy minerals.
IperionX said this includes about 3.7 million tonnes of heavy minerals.
Why the US wants projects like Titan
IperionX is positioning Titan as a domestic US source of critical mineral feedstocks at a time when supply chains remain sensitive.
The project is expected to produce heavy rare earth concentrate, titanium minerals, and zircon concentrate.
At Phase 2, annual production is forecast to include 5,287 tonnes of heavy rare earth concentrate, 118,658 tonnes of ilmenite, 24,656 tonnes of rutile, and 65,668 tonnes of zircon concentrate.
IperionX said they have potential uses across defence, aerospace, energy, robotics, semiconductors, and advanced manufacturing.
Titan is also located near road, rail, power, water, and gas infrastructure in Tennessee.
Why are the shares falling?
Today’s fall looks like a mix of profit-taking and caution around what comes next.
IperionX shares had already climbed 45% over the past year, so some investors may have used the DFS as a chance to lock in gains.
The project numbers are large, but Titan still needs US$381.3 million in total development capital across Phase 1 and Phase 2.
The next test is whether IperionX can secure funding and turn the study into a working project.
The post Why this red-hot ASX 300 stock is tumbling 10% today appeared first on The Motley Fool Australia.
Should you invest $1,000 in IperionX Ltd right now?
Before you buy IperionX Ltd shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and IperionX Ltd wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- This ASX 300 stock is back in the spotlight after a US Army test
- Why 4DMedical, IperionX, Pro Medicus, and Ventia shaares are storming higher today
- IperionX gains U.S. Army validation as titanium fasteners outperform steel
- These were the best-performing ASX 200 shares in May
- Here are the top 10 ASX 200 shares today
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.